- Email: [email protected]
EMD Millipore introduces sample preparation system
NEWS
Editorial Office: Elsevier Ltd The Boulevard, Langford Lane Kidlington, Oxford OX5 1GB, UK Fax: +44 (0)1865 843973 Web: www.membrane-technology.com Publisher: Greg Valero E-mail: [email protected] Editor: Simon Atkinson Tel/Fax: +44 (0)1904 655944 Email: [email protected] Production Support Manager: Lin Lucas E-mail: [email protected] Editorial advisory board: Dr P Ball (Pall Europe), Dr D Bessarabov (HySA Infrastructure: NWU and CSIR), Prof. M Cheryan (University of Illinois at Urbana-Champaign), Prof. A G Fane (University of New South Wales), Dr A C M Franken (Membrane Application Centre Twente), Prof. E Gobina (Robert Gordon University), Dr A Merry (Aquious–PCI Membranes), Prof. M Nyström (Lappeenranta University of Technology), Dr Anil Pabby, Bhabha Atomic Research Centre, India Dr G K Pearce (Membrane Consultancy Associates), Prof. P H Pfromm (Kansas State University), Dr R W Philpott (Acumen Bioscience Ltd), Prof. R J Wakeman (Loughborough University of Technology), Prof. A Yaroshchuk (Ukrainian Membrane Society)
Subscription Information An annual subscription to Membrane Technology includes 12 issues and online access for up to 5 users. Prices: 1215 for all European countries & Iran US$1362 for all countries except Europe and Japan ¥161 385 for Japan (Prices valid until 31 December 2011) To subscribe send payment to the address above. Tel: +44 (0)1865 843687/Fax: +44 (0)1865 834971 Email: [email protected], or via www.membrane-technology.com. Subscriptions run for 12 months, from the date payment is received. Permissions may be sought directly from Elsevier Global Rights Department, PO Box 800, Oxford OX5 1DX, UK; phone: +44 1865 843830, fax: +44 1865 853333, email: [email protected]. You may also contact Global Rights directly through Elsevier’s home page (www.elsevier.com), selecting first ‘Support & contact’, then ‘Copyright & permission’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: +1 978 750 8400, fax: +1 978 750 4744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: +44 (0)20 7631 5555; fax: +44 (0)20 7631 5500. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution. Permission of the Publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the Publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Publisher. Address permissions requests to: Elsevier Science Global Rights Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made.Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
02095 Digitally Produced by Mayfield Press (Oxford) Limited
2
Membrane Technology
Veolia Water provides system to treat produced water at PXP oilfield
V
eolia Water has signed a design– build–operate contract with Plains Exploration & Production Co (PXP) for a produced water reclamation facility at its Arroyo Grande Oilfield in San Luis Obispo County, California, USA. The treatment plant will incorporate Veolia Water’s Opus II technology to produce highquality water. This technology uses the company’s CeraMem ceramic membranes in a pretreatment stage before ion-exchange and reverse osmosis. Prior to the agreement, the Opus II process was demonstrated on-site in a pilotscale study for a period of four months. In addition to designing and building the facility – rated at 45 000 barrels per day (bpd) – Veolia Water will also run it under a twelveyear performance agreement. It will provide operations and maintenance services, and performance guarantees, on a fixed-fee basis. Over half of the treated water will be used for once through steam generation (OTSG) makeup, while the remaining 20 000 bpd capacity is available as surface-water discharge, dewatering the Arroyo Grande reservoir. The company says that the treatment process produces water that meets or exceeds state and federal permit requirements, and the dewatering of the reservoir will reduce formation pressure, enabling the production of crude oil at the site to be increased.
tive to syringe-tip filters when preparing samples for chromatography. According to Millipore, the system enables up to eight samples (even those with a high viscosity or particulates) to be simultaneously vacuum-filtered in seconds. Samples are quickly and easily loaded using a pipettor and are filtered directly into LC vials. The filtered samples are immediately ready for subsequent analyses. ‘Until now, researchers had limited options for speeding up sample preparation,’ said John Sweeney, who is head of EMD Millipore’s Life Science business field. ‘Syringe-tip filtration is a serial process that can slow down an entire workflow. At the other end of the spectrum are robotic systems, which are expensive and offer too much capacity for laboratories that handle a few dozen samples per day. The Samplicity system provides relief from the repetition of manual filtration and offers a throughput capacity well-aligned with the needs of most laboratories.’ The system is designed for use with Millex Samplicity filter units with a hydrophilic Teflon membrane filter that has a pore size of either 0.45 μm or 0.2 μm. Millex Samplicity filter units have low extractables, low analyte binding properties, and a low hold-up volume, which enables samples as small as 200 μl to be processed, says the firm. Contacts: EMD Millipore, 290 Concord Road, Billerica, MA 01821, USA. Tel: +1 978 715 4321, www.millipore.com Merck KgaA, Frankfurter Str. 250, 64293 Darmstadt, Germany. Tel: +49 6151 720, www.merck.de
Contacts: Veolia Water America Llc, 200 East Randolph Street, Suite 7900 Chicago, IL 60601. Tel: +1 312 552 2800, www.veoliawaterna.com
Hot water disinfects portable RO system for dialysis
Veolia Water Solutions & Technologies, L’Aquarène, 1 place Montgolfier, 94417 Saint Maurice Cedex, France. Tel: +33 1 4511 5555, www.veoliawaterst.com
M
EMD Millipore introduces sample preparation system
U
S-based EMD Millipore, the life science division of German company Merck KgaA has introduced the Samplicity Filtration System – described as a new technology that provides a convenient, high throughput alterna-
ar Cor Purification Inc, a wholly owned subsidiary of US-based Cantel Medical Corp, has launched a portable reverse osmosis (RO) system that is disinfected by hot water. Targeted at the dialysis market, the WRO 300H is a single-patient machine that can semi-automatically cycle through a hotwater sanitisation procedure and then return to service. Possessing FDA 510(k) status, it provides a reliable supply of water (meeting the specifications set out by the Association of Medical Instrumentation (AAMI)) and supports single-patient dialysis – working with any ‘kidney machine’ on the market, says the company.
May 2011
Editorial Office: Elsevier Ltd The Boulevard, Langford Lane Kidlington, Oxford OX5 1GB, UK Fax: +44 (0)1865 843973 Web: www.membrane-technology.com Publisher: Greg Valero E-mail: [email protected] Editor: Simon Atkinson Tel/Fax: +44 (0)1904 655944 Email: [email protected] Production Support Manager: Lin Lucas E-mail: [email protected] Editorial advisory board: Dr P Ball (Pall Europe), Dr D Bessarabov (HySA Infrastructure: NWU and CSIR), Prof. M Cheryan (University of Illinois at Urbana-Champaign), Prof. A G Fane (University of New South Wales), Dr A C M Franken (Membrane Application Centre Twente), Prof. E Gobina (Robert Gordon University), Dr A Merry (Aquious–PCI Membranes), Prof. M Nyström (Lappeenranta University of Technology), Dr Anil Pabby, Bhabha Atomic Research Centre, India Dr G K Pearce (Membrane Consultancy Associates), Prof. P H Pfromm (Kansas State University), Dr R W Philpott (Acumen Bioscience Ltd), Prof. R J Wakeman (Loughborough University of Technology), Prof. A Yaroshchuk (Ukrainian Membrane Society)
Subscription Information An annual subscription to Membrane Technology includes 12 issues and online access for up to 5 users. Prices: 1215 for all European countries & Iran US$1362 for all countries except Europe and Japan ¥161 385 for Japan (Prices valid until 31 December 2011) To subscribe send payment to the address above. Tel: +44 (0)1865 843687/Fax: +44 (0)1865 834971 Email: [email protected], or via www.membrane-technology.com. Subscriptions run for 12 months, from the date payment is received. Permissions may be sought directly from Elsevier Global Rights Department, PO Box 800, Oxford OX5 1DX, UK; phone: +44 1865 843830, fax: +44 1865 853333, email: [email protected]. You may also contact Global Rights directly through Elsevier’s home page (www.elsevier.com), selecting first ‘Support & contact’, then ‘Copyright & permission’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: +1 978 750 8400, fax: +1 978 750 4744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: +44 (0)20 7631 5555; fax: +44 (0)20 7631 5500. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution. Permission of the Publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the Publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Publisher. Address permissions requests to: Elsevier Science Global Rights Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made.Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
02095 Digitally Produced by Mayfield Press (Oxford) Limited
2
Membrane Technology
Veolia Water provides system to treat produced water at PXP oilfield
V
eolia Water has signed a design– build–operate contract with Plains Exploration & Production Co (PXP) for a produced water reclamation facility at its Arroyo Grande Oilfield in San Luis Obispo County, California, USA. The treatment plant will incorporate Veolia Water’s Opus II technology to produce highquality water. This technology uses the company’s CeraMem ceramic membranes in a pretreatment stage before ion-exchange and reverse osmosis. Prior to the agreement, the Opus II process was demonstrated on-site in a pilotscale study for a period of four months. In addition to designing and building the facility – rated at 45 000 barrels per day (bpd) – Veolia Water will also run it under a twelveyear performance agreement. It will provide operations and maintenance services, and performance guarantees, on a fixed-fee basis. Over half of the treated water will be used for once through steam generation (OTSG) makeup, while the remaining 20 000 bpd capacity is available as surface-water discharge, dewatering the Arroyo Grande reservoir. The company says that the treatment process produces water that meets or exceeds state and federal permit requirements, and the dewatering of the reservoir will reduce formation pressure, enabling the production of crude oil at the site to be increased.
tive to syringe-tip filters when preparing samples for chromatography. According to Millipore, the system enables up to eight samples (even those with a high viscosity or particulates) to be simultaneously vacuum-filtered in seconds. Samples are quickly and easily loaded using a pipettor and are filtered directly into LC vials. The filtered samples are immediately ready for subsequent analyses. ‘Until now, researchers had limited options for speeding up sample preparation,’ said John Sweeney, who is head of EMD Millipore’s Life Science business field. ‘Syringe-tip filtration is a serial process that can slow down an entire workflow. At the other end of the spectrum are robotic systems, which are expensive and offer too much capacity for laboratories that handle a few dozen samples per day. The Samplicity system provides relief from the repetition of manual filtration and offers a throughput capacity well-aligned with the needs of most laboratories.’ The system is designed for use with Millex Samplicity filter units with a hydrophilic Teflon membrane filter that has a pore size of either 0.45 μm or 0.2 μm. Millex Samplicity filter units have low extractables, low analyte binding properties, and a low hold-up volume, which enables samples as small as 200 μl to be processed, says the firm. Contacts: EMD Millipore, 290 Concord Road, Billerica, MA 01821, USA. Tel: +1 978 715 4321, www.millipore.com Merck KgaA, Frankfurter Str. 250, 64293 Darmstadt, Germany. Tel: +49 6151 720, www.merck.de
Contacts: Veolia Water America Llc, 200 East Randolph Street, Suite 7900 Chicago, IL 60601. Tel: +1 312 552 2800, www.veoliawaterna.com
Hot water disinfects portable RO system for dialysis
Veolia Water Solutions & Technologies, L’Aquarène, 1 place Montgolfier, 94417 Saint Maurice Cedex, France. Tel: +33 1 4511 5555, www.veoliawaterst.com
M
EMD Millipore introduces sample preparation system
U
S-based EMD Millipore, the life science division of German company Merck KgaA has introduced the Samplicity Filtration System – described as a new technology that provides a convenient, high throughput alterna-
ar Cor Purification Inc, a wholly owned subsidiary of US-based Cantel Medical Corp, has launched a portable reverse osmosis (RO) system that is disinfected by hot water. Targeted at the dialysis market, the WRO 300H is a single-patient machine that can semi-automatically cycle through a hotwater sanitisation procedure and then return to service. Possessing FDA 510(k) status, it provides a reliable supply of water (meeting the specifications set out by the Association of Medical Instrumentation (AAMI)) and supports single-patient dialysis – working with any ‘kidney machine’ on the market, says the company.
May 2011